China Medical University Hospital was approved by the Taiwan FDA for "Stage IV solid cancer” for treatment of autologous dendritic cell therapy on May 15, 2019.

China Medical University Hospital was approved by the Taiwan FDA for "Stage IV solid cancer” for treatment of autologous dendritic cell therapy on May 15, 2019.

"China Medical University Hospital" is one of the Ever Supreme’s collaborating medical institutes.  CMUH was approved by the Taiwan FDA for "Stage IV Solid Cancer" on treatment of autologous dendritic cell (abbreviated for DC) ) on May 15, 2019.  Availability treatment for patients who are admitted with pre-conditions on the following indications: glioblastoma multiforme and secondary brain cancer, epithelial ovarian cancer, pancreatic cancer, prostate cancer, head and neck cancer, Liver cancer, breast cancer, and colorectal cancer.

BACK